Specifically, increased levels of Tregs, CD16-CD56 positive NK cell phenotypes, and CCR2 positive monocytes are associated with a decreased risk of pulmonary fibrosis, potentially exerting protective effects by inhibiting inflammatory responses and promoting tissue repair. This evidence concerns the gene CCR2 and pulmonary fibrosis.